Psychedelic Stocks Mydecine Innovations Group (OTCMKTS:MYCOF) Contracts ethica CRO To Lead Phase 2a PTSD Clinical Trials By Larry Zweig January 05, 2021 Mydecine Innovations Group (OTCMKTS:MYCOF) has announced the engagement of ethica CRO as its contract research organization for its Phase 2a PTSD clinical studies. Ethica CRO is a full-service CRO that conducts and also managed et...
